BiomX (PHGE) Change in Account Payables (2019 - 2026)
BiomX (PHGE) posted Change in Account Payables of -$1.2 million for Q1 2026, down 129.5% sequentially from $4.1 million in Q4 2025, and down 11.62% YoY from -$1.4 million in Q1 2025.
BiomX (PHGE) Change in Account Payables (2019 - 2026) Analysis & Trends
BiomX has reported Change in Account Payables for 8 years, with the latest figure at -$1.2 million in Q1 2026.
- Quarterly Change in Account Payables fell 11.62% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 490.53% YoY) and the FY2025 annual result came in at $1.2 million, up 225.81% from the prior year.
- Change in Account Payables declined to -$1.2 million in Q1 2026 per PHGE's latest filing, from $4.1 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $4.1 million in Q4 2025 and troughed at -$3.1 million in Q3 2025.
- A 5-year average of -$36937.5 and a median of $223000.0 in 2022 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2022 and 2025: Change in Account Payables sank 483.56% in 2022, then surged 2100.54% in 2025.
- Over 5 years, Change in Account Payables stood at $1.5 million in 2022, then sank by 78.35% to $315000.0 in 2023, then slumped by 41.27% to $185000.0 in 2024, then soared by 2100.54% to $4.1 million in 2025, then tumbled by 129.5% to -$1.2 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$1.2 million, $4.1 million, and -$3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | BiomX | 351,774.34 | -816,225.66 | - | -1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.20 Mn |
| Mar 31, 2026 | -1.20 Mn |
| Dec 31, 2025 | 4.07 Mn |
| Dec 31, 2025 | 4.07 Mn |
| Sep 30, 2025 | -3.13 Mn |
| Sep 30, 2025 | -3.13 Mn |
| Jun 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | -1.08 Mn |
| Mar 31, 2025 | -1.08 Mn |
| Dec 31, 2024 | 185,000.00 |
| Dec 31, 2024 | 185,000.00 |
| Sep 30, 2024 | 1.06 Mn |
| Sep 30, 2024 | 1.06 Mn |
| Jun 30, 2024 | -454,000.00 |
| Jun 30, 2024 | -454,000.00 |
| Dec 31, 2023 | 315,000.00 |
| Dec 31, 2023 | 315,000.00 |
| Sep 30, 2023 | -1.11 Mn |
| Sep 30, 2023 | -1.11 Mn |